
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity
Faidon Magkos, Gemma Fraterrigo, Jun Yoshino, et al.
Cell Metabolism (2016) Vol. 23, Iss. 4, pp. 591-601
Open Access | Times Cited: 722
Faidon Magkos, Gemma Fraterrigo, Jun Yoshino, et al.
Cell Metabolism (2016) Vol. 23, Iss. 4, pp. 591-601
Open Access | Times Cited: 722
Showing 1-25 of 722 citing articles:
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman, Brent A. Neuschwander‐Tetri, Mary E. Rinella, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 908-922
Open Access | Times Cited: 3319
Scott L. Friedman, Brent A. Neuschwander‐Tetri, Mary E. Rinella, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 908-922
Open Access | Times Cited: 3319
Once-Weekly Semaglutide in Adults with Overweight or Obesity
John Wilding, Rachel L. Batterham, Salvatore Calanna, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 11, pp. 989-1002
Open Access | Times Cited: 2540
John Wilding, Rachel L. Batterham, Salvatore Calanna, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 11, pp. 989-1002
Open Access | Times Cited: 2540
Tirzepatide Once Weekly for the Treatment of Obesity
Ania M. Jastreboff, Louis J. Aronne, Nadia N. Ahmad, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 3, pp. 205-216
Open Access | Times Cited: 1714
Ania M. Jastreboff, Louis J. Aronne, Nadia N. Ahmad, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 3, pp. 205-216
Open Access | Times Cited: 1714
Mechanisms, Pathophysiology, and Management of Obesity
Steven B. Heymsfield, Thomas A. Wadden
New England Journal of Medicine (2017) Vol. 376, Iss. 3, pp. 254-266
Closed Access | Times Cited: 1469
Steven B. Heymsfield, Thomas A. Wadden
New England Journal of Medicine (2017) Vol. 376, Iss. 3, pp. 254-266
Closed Access | Times Cited: 1469
Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications
Michele Longo, Federica Zatterale, Jamal Naderi, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2358-2358
Open Access | Times Cited: 1220
Michele Longo, Federica Zatterale, Jamal Naderi, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2358-2358
Open Access | Times Cited: 1220
Adipose tissue inflammation and metabolic dysfunction in obesity
Tatsuo Kawai, Michael V. Autieri, Rosario Scalia
AJP Cell Physiology (2020) Vol. 320, Iss. 3, pp. C375-C391
Open Access | Times Cited: 1072
Tatsuo Kawai, Michael V. Autieri, Rosario Scalia
AJP Cell Physiology (2020) Vol. 320, Iss. 3, pp. C375-C391
Open Access | Times Cited: 1072
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
A. Michael Lincoff, Kirstine Brown‐Frandsen, Helen M. Colhoun, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 24, pp. 2221-2232
Open Access | Times Cited: 1034
A. Michael Lincoff, Kirstine Brown‐Frandsen, Helen M. Colhoun, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 24, pp. 2221-2232
Open Access | Times Cited: 1034
Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease
Alan Chait, Laura J. den Hartigh
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 1031
Alan Chait, Laura J. den Hartigh
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 1031
Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child
Patrick M. Catalano, Kartik Shankar
BMJ (2017), pp. j1-j1
Open Access | Times Cited: 991
Patrick M. Catalano, Kartik Shankar
BMJ (2017), pp. j1-j1
Open Access | Times Cited: 991
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Federica Zatterale, Michele Longo, Jamal Naderi, et al.
Frontiers in Physiology (2020) Vol. 10
Open Access | Times Cited: 771
Federica Zatterale, Michele Longo, Jamal Naderi, et al.
Frontiers in Physiology (2020) Vol. 10
Open Access | Times Cited: 771
Anti-obesity drug discovery: advances and challenges
Timo D. Müller, Matthias Blüher, Matthias H. Tschöp, et al.
Nature Reviews Drug Discovery (2021) Vol. 21, Iss. 3, pp. 201-223
Open Access | Times Cited: 688
Timo D. Müller, Matthias Blüher, Matthias H. Tschöp, et al.
Nature Reviews Drug Discovery (2021) Vol. 21, Iss. 3, pp. 201-223
Open Access | Times Cited: 688
Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over
Donna H. Ryan, Sarah R. Yockey
Current Obesity Reports (2017) Vol. 6, Iss. 2, pp. 187-194
Open Access | Times Cited: 595
Donna H. Ryan, Sarah R. Yockey
Current Obesity Reports (2017) Vol. 6, Iss. 2, pp. 187-194
Open Access | Times Cited: 595
Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence
Jacqueline Kerr, Cheryl A.M. Anderson, Scott M. Lippman
The Lancet Oncology (2017) Vol. 18, Iss. 8, pp. e457-e471
Open Access | Times Cited: 593
Jacqueline Kerr, Cheryl A.M. Anderson, Scott M. Lippman
The Lancet Oncology (2017) Vol. 18, Iss. 8, pp. e457-e471
Open Access | Times Cited: 593
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
Gordon I. Smith, Mahalakshmi Shankaran, Mihoko Yoshino, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 3, pp. 1453-1460
Open Access | Times Cited: 549
Gordon I. Smith, Mahalakshmi Shankaran, Mihoko Yoshino, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 3, pp. 1453-1460
Open Access | Times Cited: 549
Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: A pilot study
Kelsey Gabel, Kristin K. Hoddy, Nicole Haggerty, et al.
Nutrition and Healthy Aging (2018) Vol. 4, Iss. 4, pp. 345-353
Open Access | Times Cited: 527
Kelsey Gabel, Kristin K. Hoddy, Nicole Haggerty, et al.
Nutrition and Healthy Aging (2018) Vol. 4, Iss. 4, pp. 345-353
Open Access | Times Cited: 527
Why does obesity cause diabetes?
Samuel Klein, Amalia Gastaldelli, Hannele Yki‐Järvinen, et al.
Cell Metabolism (2022) Vol. 34, Iss. 1, pp. 11-20
Open Access | Times Cited: 482
Samuel Klein, Amalia Gastaldelli, Hannele Yki‐Järvinen, et al.
Cell Metabolism (2022) Vol. 34, Iss. 1, pp. 11-20
Open Access | Times Cited: 482
Metabolically healthy obesity: facts and fantasies
Gordon I. Smith, Bettina Mittendorfer, Samuel Klein
Journal of Clinical Investigation (2019) Vol. 129, Iss. 10, pp. 3978-3989
Open Access | Times Cited: 481
Gordon I. Smith, Bettina Mittendorfer, Samuel Klein
Journal of Clinical Investigation (2019) Vol. 129, Iss. 10, pp. 3978-3989
Open Access | Times Cited: 481
The aetiology and molecular landscape of insulin resistance
David E. James, Jacqueline Stöckli, Morris J. Birnbaum
Nature Reviews Molecular Cell Biology (2021) Vol. 22, Iss. 11, pp. 751-771
Closed Access | Times Cited: 437
David E. James, Jacqueline Stöckli, Morris J. Birnbaum
Nature Reviews Molecular Cell Biology (2021) Vol. 22, Iss. 11, pp. 751-771
Closed Access | Times Cited: 437
Causes, consequences, and treatment of metabolically unhealthy fat distribution
Norbert Stefan
The Lancet Diabetes & Endocrinology (2020) Vol. 8, Iss. 7, pp. 616-627
Closed Access | Times Cited: 430
Norbert Stefan
The Lancet Diabetes & Endocrinology (2020) Vol. 8, Iss. 7, pp. 616-627
Closed Access | Times Cited: 430
Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity
Dylan A Lowe, Nancy Wu, Linnea Rohdin-Bibby, et al.
JAMA Internal Medicine (2020) Vol. 180, Iss. 11, pp. 1491-1491
Open Access | Times Cited: 395
Dylan A Lowe, Nancy Wu, Linnea Rohdin-Bibby, et al.
JAMA Internal Medicine (2020) Vol. 180, Iss. 11, pp. 1491-1491
Open Access | Times Cited: 395
An Integrated View of Immunometabolism
Yun Sok Lee, Joshua Wollam, Jerrold M. Olefsky
Cell (2018) Vol. 172, Iss. 1-2, pp. 22-40
Open Access | Times Cited: 373
Yun Sok Lee, Joshua Wollam, Jerrold M. Olefsky
Cell (2018) Vol. 172, Iss. 1-2, pp. 22-40
Open Access | Times Cited: 373
Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
Ildiko Lingvay, Priya Sumithran, Ricardo V. Cohen, et al.
The Lancet (2021) Vol. 399, Iss. 10322, pp. 394-405
Closed Access | Times Cited: 368
Ildiko Lingvay, Priya Sumithran, Ricardo V. Cohen, et al.
The Lancet (2021) Vol. 399, Iss. 10322, pp. 394-405
Closed Access | Times Cited: 368
Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus
Maggie S. Burhans, Derek Hagman, Jessica N. Kuzma, et al.
Comprehensive physiology (2018), pp. 1-58
Open Access | Times Cited: 355
Maggie S. Burhans, Derek Hagman, Jessica N. Kuzma, et al.
Comprehensive physiology (2018), pp. 1-58
Open Access | Times Cited: 355
Diet and exercise in the prevention and treatment of type 2 diabetes mellitus
Faidon Magkos, Mads F. Hjorth, Arne Astrup
Nature Reviews Endocrinology (2020) Vol. 16, Iss. 10, pp. 545-555
Closed Access | Times Cited: 350
Faidon Magkos, Mads F. Hjorth, Arne Astrup
Nature Reviews Endocrinology (2020) Vol. 16, Iss. 10, pp. 545-555
Closed Access | Times Cited: 350
Gut Microbiome Fermentation Determines the Efficacy of Exercise for Diabetes Prevention
Yan Liu, Yao Wang, Yueqiong Ni, et al.
Cell Metabolism (2019) Vol. 31, Iss. 1, pp. 77-91.e5
Open Access | Times Cited: 297
Yan Liu, Yao Wang, Yueqiong Ni, et al.
Cell Metabolism (2019) Vol. 31, Iss. 1, pp. 77-91.e5
Open Access | Times Cited: 297